
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
ANN ARBOR, Mich., May 26, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that cocoon collection has begun for its current recombinant spider silk production cycle.

Kraig Labs (OTCQB: KBLB) provides additional details regarding the significant advantages of its newly developed immortalized silk gland cell platform

Kraig Labs (OTCQB:KBLB) latest breakthrough could form the foundation for a next-generation biotechnology platform with potential applications in biopharma

DENVER, May 13, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com ) – The global plastics crisis is no longer just an environmental debate, it's now an industrial-scale economic, healthcare, and infrastructure problem with trillion-dollar implications. The world currently produces more than 400 million metric tons of plastic annually, and that number is expected to approach 500 million tons within just a few years.

ANN ARBOR, Mich., May 11, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced the successful commissioning of another recombinant spider silk production rearing center.

DENVER, May 07, 2026 (GLOBE NEWSWIRE) -- (www.247marketnews.com) - In a sector filled with bold claims but limited real-world execution, Kraig Biocraft Laboratories (OTCQB: KBLB) is emerging as a serious contender in the global race to commercialize spider silk, backed not just by promise, but by validated science and advancing production capability. The race to commercialize spider silk, a material long hailed as one of the toughest and most versatile fibers on Earth, has attracted a wide field of innovators.

ANN ARBOR, Mich., May 04, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that it has officially launched its next production cycle following the Company's recent record-setting production run.

ANN ARBOR, Mich. , May 04, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that it has officially launched its next production cycle following the Company's recent record-setting production run.

DENVER, April 30, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com )- Kraig Biocraft Laboratories (OTCQB: KBLB) (“Kraig Labs” or the “Company”), a leading developer of recombinant spider silk-based fibers, has achieved two major commercialization milestones, signaling accelerating momentum toward the first successful spider silk commercialization program. The Company announced that a recent production run yielded approximately 1.8 metric tons of recombinant spider silk, marking a significant increase in output and establishing a new benchmark for commercial-scale production.

ANN ARBOR, Mich., April 28, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced significant progress in the processing of its recently produced recombinant spider silk cocoons into reeled silk.

ANN ARBOR, Mich., April 20, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that it has begun processing nearly 1.8 metric tons of recombinant spider silk cocoons into finished reeled silk.

DENVER, April 15, 2026 (GLOBE NEWSWIRE) -- (www.247marketnews.com ) -- The recent move by Ken Paxton to investigate Lululemon should be a wake-up call. This isn't just about one brand, or just one topic; the entire synthetic textile industry needs to be reconsidered.

ANN ARBOR, Mich., April 13, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that senior management is traveling to South East Asia this week to build on the momentum of its recently announced record-setting production of 1.3 metric tons of recombinant spider silk cocoons in a single month.

Spider silk's extraordinary combination of strength, elasticity, toughness, biocompatible, biodegradable, and low weight, properties that outperform Kevlar

ANN ARBOR, Mich., April 06, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that it has produced more than 1.3 metric tons of recombinant spider silk cocoons in a single month.

DENVER, April 02, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com ) -- Kraig Biocraft Laboratories (OTCQB: KBLB) is advancing a transgenic silkworm platform designed to produce recombinant spider silk at commercial scale, positioning the company at the intersection of genetic engineering, materials science, and textile manufacturing. Spider silk has long been studied for its combination of strength, elasticity, and low weight.

ANN ARBOR, Mich., March 30, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced the successful deployment of more than 700,000 BAM-1 Alpha production hybrids of its previously reported 1,000,000 egg inventory.

ANN ARBOR, Mich., March 23, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced a significant expansion of its research and development capacity designed to keep pace with rapid progress of its advanced materials initiative, Project Atlas.

Kraig Labs (OTCQB: KBLB) plans to use multiple production facilities in Vietnam to produce around 10 metric tons of recombinant spider-silk cocoons per mon

DENVER, March 11, 2026 (GLOBE NEWSWIRE) -- 247marketnews.com -- In technology and biotechnology, “unicorn” status is typically reserved for private companies valued at $1 billion or more; often backed by major venture rounds, institutional syndicates, and aggressive capital deployment strategies. But what happens when a company advances a platform with billion-dollar potential without the backing of Silicon Valley mega-funding?
